Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.48 EUR | -1.53% | +2.52% | -42.24% |
Apr. 09 | BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%) | |
Apr. 09 | Bastide: new contract with the British NHS | CF |
Sales 2024 * | 532M 568M | Sales 2025 * | 570M 609M | Capitalization | 116M 124M |
---|---|---|---|---|---|
Net income 2024 * | 19M 20.3M | Net income 2025 * | 22M 23.51M | EV / Sales 2024 * | 0.91 x |
Net Debt 2024 * | 367M 392M | Net Debt 2025 * | 337M 360M | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
5.93
x | P/E ratio 2025 * |
5.23
x | Employees | 3,635 |
Yield 2024 * |
2.99% | Yield 2025 * |
3.72% | Free-Float | 44.92% |
1 day | -0.25% | ||
1 week | -1.63% | ||
Current month | +11.49% | ||
1 month | -11.59% | ||
3 months | -35.31% | ||
6 months | -28.87% | ||
Current year | -41.34% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 15.48 | -1.53% | 14 164 |
24-04-17 | 15.72 | -0.25% | 5,587 |
24-04-16 | 15.76 | +3.41% | 10,229 |
24-04-15 | 15.24 | -3.18% | 7,989 |
24-04-12 | 15.74 | +4.24% | 14,099 |
Real-time Euronext Paris, April 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.34% | 124M | |
-4.31% | 2.97B | |
0.00% | 1.76B | |
+4.06% | 1.55B | |
+43.75% | 601M | |
-1.84% | 510M | |
-39.89% | 350M | |
-13.74% | 135M | |
+3.85% | 71.51M |
- Stock Market
- Equities
- BLC Stock